Profiles for companies starting with 'n'
✉ Email this page to a colleague
Drugs and US Patents for n
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Noven Pharms Inc | XELSTRYM | dextroamphetamine | SYSTEM;TRANSDERMAL | 215401-003 | Mar 22, 2022 | RX | Yes | No | 8,591,941 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Novartis | FABHALTA | iptacopan hydrochloride | CAPSULE;ORAL | 218276-001 | Dec 5, 2023 | RX | Yes | Yes | 11,603,363 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Numark | MELFIAT-105 | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 087487-001 | Oct 13, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Nesher Pharms | DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 075609-002 | Oct 18, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Novartis | AFINITOR | everolimus | TABLET;ORAL | 022334-002 | Mar 30, 2009 | AB | RX | Yes | No | 8,410,131*PED | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |